IMA Stock Price Chart
IMA Earnings
ImageneBio Inc
$5.29
-10.49%
$-0.62
At close: May 08, 16:00:00 GMT-4
$5.41
2.26%
$0.12
Post-market: May 08, 20:00:00 GMT-4
Back
ImageneBio Inc (IMA) Earnings
Key Stats
Prev.Close
$5.91
Open
$5.68
Day's Range
$5.29 - $5.9
52 week range
$3.94 - $18
Volume
74.3K
Avg.Volume
259.4K
Dividend yield
--
EPS (TTM)
-4.45
Market Cap
$57.6M
What is IMA?
Ikena Oncology, Inc. is a clinical stage biotechnology company, which engages in the development of patient directed and biomarker driven therapies for cancer patients. The company is headquartered in Boston, Massachusetts and currently employs 10 full-time employees. The company went IPO on 2021-03-26. The firm is focused on developing differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. Its lead program in the RAS pathway, IK-595, is a molecular glue designed to trap MEK and RAF in an inactive complex, more completely inhibiting RAS signals than existing inhibitors. IK-595’s ability to complex the RAFs, including CRAF prevents a signaling bypass mechanism that cancer cells employ to drive therapeutic resistance to other drugs in this class. IK-595 is being developed as an oral therapy and evaluated in a Phase I clinical trial in RAS and RAF mutant cancers.
